PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

97 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
21.
Lehn-Stefan, A. et al.: Impaired metabolic health and low cardiorespiratory fitness independently associate with subclinical atherosclerosis in obesity. J. Clin. Endocrinol. Metab. 107, e2417-e2424 (2022)
22.
Li, Z.* et al.: Childhood height growth rate association with the risk of islet autoimmunity and development of type 1 diabetes. J. Clin. Endocrinol. Metab. 107, 1520-1528 (2022)
23.
Sulaj, A.* et al.: Six-month periodic fasting in patients with type 2 diabetes and diabetic nephropathy: A proof-of-concept study. J. Clin. Endocrinol. Metab. 107, 2167-2181 (2022)
24.
Wang, M.* et al.: Circulating levels of microRNA-122 and hepatic fat change in response to weight-loss interventions: CENTRAL Trial. J. Clin. Endocrinol. Metab. 107, E1899-E1906 (2022)
25.
Webb-Robertson, B.M.* et al.: Integration of infant metabolite, genetic and islet autoimmunity signatures to predict type 1 diabetes by 6 years of age. J. Clin. Endocrinol. Metab. 107, 2329-2338 (2022)
26.
Dannecker, C. et al.: Low-density lipoprotein cholesterol is associated with insulin secretion. J. Clin. Endocrinol. Metab. 106, 1576-1584 (2021)
27.
Erlic, Z.* et al.: Targeted metabolomics as a tool in discriminating endocrine from primary hypertension. J. Clin. Endocrinol. Metab. 106, 1111-1128 (2021)
28.
Hörber, S. et al.: Lifestyle intervention improves prothrombotic coagulation profile in individuals at high-risk for type 2 diabetes. J. Clin. Endocrinol. Metab. 106, E3198-E3207 (2021)
29.
Kullmann, S. et al.: Central insulin modulates dopamine signaling in the human striatum. J. Clin. Endocrinol. Metab. 106, 2949-2961 (2021)
30.
Lehn-Stefan, A. et al.: Elevated circulating glutamate associates with subclinical atherosclerosis independently of established risk markers: A cross-sectional study. J. Clin. Endocrinol. Metab. 106, e982-e989 (2021)
31.
Rottenkolber, M. et al.: A pathophysiology of type 2 diabetes unrelated to metabolic syndrome. J. Clin. Endocrinol. Metab. 106, 1460-1471 (2021)
32.
Thorand, B. et al.: A panel of six biomarkers significantly improves the prediction of type 2 diabetes in the MONICA/KORA study population. J. Clin. Endocrinol. Metab. 106, e1647-e1659 (2021)
33.
Bardugo, A.* et al.: Adolescent nonalcoholic fatty liver disease and type 2 diabetes in young adulthood. J. Clin. Endocrinol. Metab. 106, e34-e44 (2020)
34.
Bornstein, S.R.* et al.: New horizons: Novel adrenal regenerative therapies. J. Clin. Endocrinol. Metab. 105, 3103-3107 (2020)
35.
Hoffmann, C.* et al.: Response of mitochondrial respiration in adipose tissue and muscle to 8 weeks of endurance exercise in obese subjects. J. Clin. Endocrinol. Metab. 105:dgaa571 (2020)
36.
Hu, C.* et al.: Muscle-liver substrate fluxes in exercising humans and potential effects on hepatic metabolism. J. Clin. Endocrinol. Metab. 105, 1196–1209 (2020)
37.
Pozzilli, P.* et al.: Randomized 52-week phase 2 trial of albiglutide vs placebo in adult patients with newly diagnosed type 1 diabetes. J. Clin. Endocrinol. Metab. 105, e2192–e2206 (2020)
38.
Randrianarisoa, E. et al.: AMPK subunits harbor largely non-overlapping genetic determinants for body fat mass, glucose- and cholesterol metabolism. J. Clin. Endocrinol. Metab. 105, 14-25:dgz020 (2020)
39.
Tofte, N.* et al.: Plasma metabolomics identifies markers of impaired renal function: A meta-analysis of 3,089 persons with type 2 diabetes. J. Clin. Endocrinol. Metab. 105:dgaa173 (2020)
40.
Wagner, R. et al.: Pancreatic steatosis associates with impaired insulin secretion in genetically predisposed individuals. J. Clin. Endocrinol. Metab. 105:dgaa435 (2020)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮